Company intelligence / Profile preview

Orthopedic Tissue Sciences

Birmingham, Alabama, United States

Ownership: Private
Development stage: Other

Overview

Orthopedic Tissue Sciences (OTS) was a biotechnology company focused on the development and commercialization of advanced orthopedic biologics and tissue-engineered products. The company specialized in regenerative medicine solutions designed to enhance bone and soft tissue healing in surgical procedures. Its portfolio included human-derived tissue grafts and scaffolds used in joint preservation and reconstructive surgery. In 2014, the company was acquired by NuTech Medical, which was subsequently acquired by Organogenesis in 2017. Today, the legacy of OTS's technology is integrated into the broader regenerative medicine offerings of Organogenesis.

Therapeutic areas: RheumatologyOther
Modalities: BiologicDevice
Industry: Surgical Medical Devices

Beyond the preview

Go deeper on Orthopedic Tissue Sciences.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Orthopedic Tissue Sciences.

Explore the full profile